Search results
Results from the WOW.Com Content Network
The Standards of Care for the Health of Transgender and Gender Diverse People (SOC) is an international clinical protocol by the World Professional Association for Transgender Health (WPATH) outlining the recommended assessment and treatment for transgender and gender-diverse individuals across the lifespan including social, hormonal, or surgical transition. [1]
Researchers were able to identify a total of 13,994 minors across the United States who received medical treatment for gender dysphoria over the course of four years. Shockingly, over 5,700 of ...
A 2021 meta analysis found that 15 percent of intersex people born with ambiguous sex characteristics experience gender dysphoria in adolescence or adulthood. [77] Patients with 5-alpha-reductase deficiency and 17-hydroxysteroid dehydrogenase deficiency have the highest prevalence of gender dysphoria, while those with CAH have the lowest ...
Medications and dosages used in transgender women [1] [2] [3] [4] [5] [a]; Medication Brand name Type Route Dosage [b]; Estradiol: Various: Estrogen: Oral: 2–10 mg ...
The ACLU of Missouri and Lambda Legal said they will appeal a judge's ruling that restrictions on gender-affirming care for minors are constitutional. Upholding state ban, judge says transgender ...
Gender nonconformity is not the same as gender dysphoria; nonconformity, according to the standards of care, is not a pathology and does not require medical treatment. The informed consent model is an alternative to the standard WPATH approach which does not require a person seeking transition related medical treatment to undergo formal ...
While the therapy cannot undo the effects of a person's first puberty, developing secondary sex characteristics associated with a different sex can relieve some or all of the distress and discomfort associated with gender dysphoria, and can help the person to "pass" or be seen as their gender identity. Introducing exogenous (not internally ...
(The Center Square) – The U.S. Supreme Court on Wednesday began weighing its role in determining whether a Tennessee law banning medication to treat gender dysphoria for minors violates the ...